Targeted Sequencing
Targeted Sequencing Market by Product Type (Consumables, Platforms, Services), Application (Cardiovascular Diseases, Hereditary Diseases, Infectious Diseases), End-User - Global Forecast 2024-2030
360iResearch Analyst
Want to know more about the targeted sequencing market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[198 Pages Report] The Targeted Sequencing Market size was estimated at USD 6.23 billion in 2023 and expected to reach USD 7.60 billion in 2024, at a CAGR 20.30% to reach USD 22.73 billion by 2030.

Targeted sequencing is a rapid and cost-effective way to detect known and novel variants in selected genes or genomic regions. It targets genes or regions of interest to analyze genetic variations and is widely applied in clinical diagnostics, oncology, agriculture, and other precision medicine applications. End-use segments include academic and research institutions, pharmaceutical and biotechnology companies, healthcare facilities, and diagnostic laboratories. Targeted sequencing is implemented in various areas, including personalized medicine, infectious disease research, genetic disorder analysis, and crop improvement. Its use in clinical settings for identifying and treating cancer and inherited genetic disorders and tracking disease outbreaks makes it an invaluable tool. Biotechnological advancements in agriculture leverage targeted sequencing for crop trait development, thus contributing to sustainable food production. Growth is fueled by technological advancements that enable quicker, cheaper sequencing, as well as increased public interest in personal health analytics, supported by governmental and private funding for research. Promising sectors for expansion include integrated sequencing-bioinformatics platforms and non-invasive diagnostics, with untapped potential in emerging economies’ healthcare and research sectors. However, challenges include intellectual property battles and ethical dilemmas regarding genomic data. Stakeholders are expected to innovate in panel versatility, data analysis software accessibility, and sample processing and advocate for global sequencing standards to facilitate data interoperability.
Regional Insights

The targeted sequencing market exhibits significant geographical diversity, with the United States at the forefront in North America due to advanced healthcare infrastructure, robust R&D investments, and a thriving pharmaceutical sector. At the same time, Canada follows with strong government support for genomics. In Europe, countries such as Germany, the United Kingdom, France, and Italy significantly contribute to the market, benefiting from substantial EU funding and collaborative research environments. The Middle East and Africa (MEA) region, including the United Arab Emirates and South Africa, sees targeted sequencing gain traction due to increased investment in healthcare infrastructure, though limited research funding persists. Asia-Pacific countries, including China, Japan, and India, show strong growth potential, driven by government investments, R&D focus, and initiatives such as the Genome India Project. Latin America, with Brazil and Mexico, and the ASEAN region, including Singapore and Malaysia, also present growth opportunities amidst economic and funding challenges. Consumer needs and purchasing behavior trends vary, with Asia-Pacific consumers prioritizing advanced healthcare and precision medicine. At the same time, there is a strong demand for high-quality healthcare and innovation in the Americas. EMEA consumers value advanced clinical applications and comprehensive healthcare services. The market outlook highlights substantial patents, research, and investment activities, with the United States emphasizing cancer research, China's progress in large-scale genomic projects, EU funding for transnational research, Japan's integration of AI with sequencing technologies, and India's infrastructure investments.

The regulatory frameworks for targeted sequencing differ across regions, with the United States Food and Drug Administration (FDA) emphasizing safety and efficacy through stringent approvals, the European Medicines Agency (EMA) streamlining approvals with some variations across member states, and China's National Medical Products Administration (NMPA) rapidly evolving to expedite innovative technologies. Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) stresses post-market surveillance, while India's Central Drugs Standard Control Organization (CDSCO) is becoming more structured, providing streamlined clinical trial procedures.

Targeted Sequencing Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Targeted Sequencing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Extensive adoption of targeted sequencing technologies in clinical diagnostics due to rapid result time and higher accuracy
    • Emerging adoption in the agriculture sector to analyze the genetic potential of plants
    • Increased application of targeted sequencing for precision medicines
  • Market Restraints
    • Lack of the computational resources and staffing to analyze and interpret clinical data
  • Market Opportunities
    • Continuous focus on new technology development novel targeted sequencing technologies
    • Increased support from government and private sector for large scale sequencing technology
  • Market Challenges
    • Ethical and privacy concerns related to targeted sequencing data protection
Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Targeted Sequencing Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Targeted Sequencing Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Targeted Sequencing Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Targeted Sequencing Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Targeted Sequencing Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Targeted Sequencing Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Targeted Sequencing Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Targeted Sequencing Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Targeted Sequencing Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Targeted Sequencing Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Targeted Sequencing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Targeted Sequencing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Targeted Sequencing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Targeted Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., A-Alpha Bio, Inc., Agilent Technologies, Inc., Azenta Life Sciences, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., CD Genomics, DH Life Sciences, LLC, Element Biosciences, F. Hoffmann-La Roche Ltd., Illumina, Inc., LGC Limited, Macrogen, Inc., MGI Tech Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Paragon Genomics, Inc., PerkinElmer, Inc., Psomagen, Inc., QIAGEN N.V., Singular Genomics Systems, Inc., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Targeted Sequencing Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Targeted Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Consumables
    • Platforms
    • Services
  • Application
    • Cardiovascular Diseases
    • Hereditary Diseases
    • Infectious Diseases
    • Neurological Disorders
    • Oncology
    • Reproductive Health
  • End-User
    • Academic & Research Institutes
    • Clinical Laboratories
    • Contract Research Organization
    • Pharmaceutical & Biotechnology Companies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Targeted Sequencing Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Targeted Sequencing Market, by Product Type
  7. Targeted Sequencing Market, by Application
  8. Targeted Sequencing Market, by End-User
  9. Americas Targeted Sequencing Market
  10. Asia-Pacific Targeted Sequencing Market
  11. Europe, Middle East & Africa Targeted Sequencing Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 294]
  16. List of Companies Mentioned [Total: 25]
Frequently Asked Questions
  1. How big is the Targeted Sequencing Market?
    Ans. The Global Targeted Sequencing Market size was estimated at USD 6.23 billion in 2023 and expected to reach USD 7.60 billion in 2024.
  2. What is the Targeted Sequencing Market growth?
    Ans. The Global Targeted Sequencing Market to grow USD 22.73 billion by 2030, at a CAGR of 20.30%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.